You can watch IMRNW and buy or sell other stocks, options, and ETFs commission-free!
Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States.
Jerry Kanellos, PhD
Carlton, Victoria (VIC)
52 Week High
52 Week Low